Insider transactions Arrowhead Pharmaceuticals, Inc.
Stocks
ARWR
US04280A1007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.38 USD | -0.62% |
|
-15.03% | +7.51% |
| 06-29 | Arrowhead Pharmaceuticals, Inc.(NasdaqGS:ARWR) dropped from Russell 2000 Index | CI |
| 06-29 | Arrowhead Pharmaceuticals, Inc.(NasdaqGS:ARWR) added to Russell Midcap Value Benchmark | CI |
Insider Transaction History
Latest insider transactions for Arrowhead Pharmaceuticals, Inc.
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 15/06/26 | Other | Director | 0 | 81.82 | - | 0% | ||
| 15/06/26 | Free | Director | 11,882 | - | - | 0.0084% | ||
| 12/05/26 | Sell | Director | -2,970 | 76.88 | - | 0.0021% | ||
| 05/03/26 | Sell | Chief Technology Officer | 10,000 | 64.19 | 642K | 0.0071% | ||
| 06/01/26 | Free | Chief Financial Officer | 75,000 | - | - | 0.0552% | ||
| 06/01/26 | Free | Chief Technology Officer | 75,000 | - | - | 0.0552% | ||
| 06/01/26 | Don | Chief Operating Officer | 77,500 | - | - | 0.0571% | ||
| 05/01/26 | Sell | Chief Technology Officer | 40,164 | 63.11 | 2.53M | 0.0296% | ||
| 02/01/26 | Sell | Chief Executive Officer | 13,187 | 66.10 | 872K | 0.0097% | ||
| 31/12/25 | Don | Chief Operating Officer | 52,293 | 59.73 | 3.12M | 0.0385% | ||
| 29/12/25 | Fiscal year | Chief Executive Officer | 155,178 | 37.64 | 3.89M | 0.1143% | ||
| 26/12/25 | Sell | Director | 7,530 | 70.00 | 527K | 0.0055% | ||
| 19/12/25 | Sell | Chief Executive Officer | 26,031 | 68.04 | 1.77M | 0.0192% | ||
| 19/12/25 | Sell | Director | 8,367 | 67.65 | 566K | 0.0062% | ||
| 19/12/25 | Sell | Director | 10,040 | 67.68 | 679K | 0.0074% | ||
| 19/12/25 | Sell | Director | 10,000 | 67.66 | 677K | 0.0074% | ||
| 17/12/25 | Sell | Chief Executive Officer | 85,000 | 64.04 | 5.44M | 0.0626% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 16/12/25 | Free | Director | 7,819 | - | - | 0.0058% | ||
| 12/12/25 | Free | Chief Executive Officer | 364,298 | 33.90 | 12.35M | 0.2682% | ||
| 05/12/25 | Sell | Director | 16,250 | 61.03 | 992K | 0.0120% | ||
| 28/11/25 | Sell | Director | 8,750 | 56.39 | 493K | 0.0063% | ||
| 01/10/25 | Sell | Chief Technology Officer | 20,000 | 35.00 | 700K | 0.0159% | ||
| 12/09/25 | Sell | Chief Technology Officer | 15,000 | 30.00 | 450K | 0.0119% | ||
| 02/09/25 | Sell | Chief Technology Officer | 15,000 | 25.00 | 375K | 0.0119% | ||
| 13/08/25 | Sell | Chief Technology Officer | 10,000 | 20.00 | 200K | 0.0079% | ||
| 15/04/25 | Other | Chief Financial Officer | 101,200 | - | - | 0.0803% | ||
| 09/04/25 | Sell | Chief Executive Officer | 141,122 | 10.87 | 1.53M | 0.1119% | ||
| 13/03/25 | Free | Chief Executive Officer | 391,425 | 1.98 | 775K | 0.3104% | ||
| 03/03/25 | Fiscal year | Chief Executive Officer | 900,000 | 12.67 | 7.6M | 0.7137% | ||
| 07/02/25 | Free | Chief Executive Officer | 9,550 | 20.10 | 192K | 0.0076% | ||
| 06/02/25 | Other | Director | 0 | - | - | 0% | ||
| 06/02/25 | Free | Director | 38,396 | 20.09 | 771K | 0.0307% | ||
| 23/01/25 | Sell | Director | 959 | 21.00 | 20.14K | 0.0008% | ||
| 04/01/25 | Free | Chief Financial Officer | 145,167 | 6.15 | 893K | 0.1167% | ||
| 04/01/25 | Free | Chief Technology Officer | 132,729 | 4.89 | 649K | 0.1067% | ||
| 04/01/25 | Free | Chief Operating Officer | 137,184 | 5.37 | 736K | 0.1102% | ||
| 02/01/25 | Sell | Chief Executive Officer | 11,520 | 19.05 | 219K | 0.0093% | ||
| 27/12/24 | Sell | Director | 2,850 | 20.00 | 57K | 0.0023% | ||
| 23/12/24 | Sell | Chief Executive Officer | 12,563 | 19.59 | 246K | 0.0101% | ||
| 18/12/24 | Free | Director | 16,733 | 22.99 | 385K | 0.0134% | ||
| 18/12/24 | Free | Director | 16,733 | 22.99 | 385K | 0.0134% | ||
| 18/12/24 | Free | Director | 16,733 | 22.99 | 385K | 0.0134% | ||
| 18/12/24 | Free | Director | 16,733 | 22.99 | 385K | 0.0134% | ||
| 18/12/24 | Sell | Chief Executive Officer | 126,712 | 4.48 | 567K | 0.1018% | ||
- Stock Market
- Stocks
- ARWR Stock
- Company Arrowhead Pharmaceuticals, Inc.
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















